Puma Biotechnology Inc. (NASDAQ: PBYI) common stock trades at approximately $9.24 per share. The equity moves within a 52-week trading range defined by a lower support baseline near $4.30 and an upper peak resistance reaching around $9.51, backed by a small-cap market capitalization of roughly $477 million.